What is MoonLake Immunotherapeutics's net change in cash?

MoonLake Immunotherapeutics (MLTX) reported net change in cash of -$36.03M in Q1 2026.

How has MoonLake Immunotherapeutics's net change in cash changed year-over-year?

MoonLake Immunotherapeutics's net change in cash decreased by 139.5% year-over-year, from $91.14M to -$36.03M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

MoonLake Immunotherapeutics MLTX Net Change in Cash

Net Change in Cash at other companies

Eli LillyLLY

-$1.99B-1,035%

Oruka Therapeutics, Inc.ORKA

$2.59M-88.2%

AnaptysBio, Inc.ANAB

$10.27M+142%

Opko HealthOPK

-$27.18M-769%

Nektar TherapeuticsNKTR

$134.46M+2,610%

Aurinia PharmaceuticalsAUPH

-$39.21M-131%

Other financials

Income statement

See full

Operating income-$70.0M-47.5%

Net income-$69.7M-74.5%

EPS (diluted)-$0.98-55.6%

Balance sheet

See full

Cash & equivalents$298.5M+9.9%

Total debt$100.8M+33.3%

Total equity$254.0M-37.7%

Total assets$400.4M-21.7%

Cash flow

See full

Operating cash flow-$66.3M-73.8%

CapEx--100%

Free cash flow-$66.3M-73.6%

Valuation

See full

Market cap$1.49B-45.9%

Enterprise value$1.29B-50.0%

Returns & leverage

See full

Return on equity-77.7%-221pp

Debt / equity0.4×+0.2×

Current ratio8.6×-12.5×

Where this comes from

Reported directly by MoonLake Immunotherapeutics in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about MoonLake Immunotherapeutics's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MoonLake Immunotherapeutics's net change in cash?: MoonLake Immunotherapeutics (MLTX) reported net change in cash of -$36.03M in Q1 2026.
How has MoonLake Immunotherapeutics's net change in cash changed year-over-year?: MoonLake Immunotherapeutics's net change in cash decreased by 139.5% year-over-year, from $91.14M to -$36.03M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.